EX-11 5 amendexhibit111.htm EXHIBIT 11.1 Bioanalytical Systems, Inc. - Exhibit 11.1

Exhibit 11.1 — Statement Regarding Computation of Per share Earnings


(Unaudited)
(in thousands, except per share data)


Three Months Ended
June 30, 2003
Three Months Ended
June 30, 2002
Nine Months Ended
June 30, 2003
Nine Months Ended
June 30, 2002
Basic                    
  Average Common Shares  
  outstanding    4,605    4,578    4,595    4,575  
Net income   $ 354   $ 281   $ 462   $ 1,047  
Per share amount   $ .08   $ .06   $ .10   $ .23  
Diluted  
     Average Common Shares  
     outstanding    4,605    4,578    4,595    4,575  
     Net effect of dilutive stock  
     options based on the  
     Treasury stock method  
     using the average market price  
     4    37    21    45  
Total    4,609    4,615    4,616    4,620  
Net income   $ 354   $ 281   $ 462   $ 1,047  
Per share amount   $ .08   $ .06   $ .10   $ .23